Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.64%
#2 PulseChain PulseChain +59.45%
#3 BOOK OF MEME BOOK OF MEME +34.33%
#4 Merlin's Seal BTC Merlin's Seal BTC +32.88%
#5 Ontology Gas Ontology Gas +28.49%
#6 Unit Pump Unit Pump +24.72%
#7 Pump.fun Pump.fun +24.72%
#8 Nockchain Nockchain +22.61%
#9 Neiro Neiro +21.92%
#10 ConstitutionDAO ConstitutionDAO +20.25%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rank in Stocks #26706
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Share Price
$0.12164306
Last synced: 2024-11-11
Market Cap
$38.53M
Change (1 day)
-4.14%
Change (1 year)
0.00%
Country
AU
Trade PharmAust Limited (PAA)

Category

Healthcare
EPS for PharmAust Limited (PAA)
EPS as of June 2024 TTM: $-0.01
According to PharmAust Limited latest financial reports and stock price the company's current EPS (TTM) is $-0.01. At the end of 2023 the company had a EPS of $-0.01 a decrease compared to its 2022 EPS that were of $0.00.
EPS history for PharmAust Limited from 2001 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -148,134.19%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -237,194.02%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -25,570.09%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 68,105.13%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH